Abstract
It has been proven that the virus of the new coronavirus infection SARS-CoV-2 enters the body not only through the respiratory tract, but also through the cells of the gastrointestinal tract, on the surface of which receptors (or entry gates) for the virus are also found, which leads to damage to the mucous membrane gastrointestinal tract. For the treatment of a new coronavirus infection, schemes are used to protect the mucous membrane, including gastroprotective drugs.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
